|

Pharmacogenomics-Supported Psychotropic Prescribing Trial

RECRUITINGN/ASponsored by University of Manitoba
Actively Recruiting
PhaseN/A
SponsorUniversity of Manitoba
Started2025-07-01
Est. completion2028-12-31
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT06929533

Summary

Investigate the feasibility and utility of implementing pharmacogenetic testing for adults (aged 18 and older) seeking care for mental illness in Manitoba.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Aged 18 years or older
* The initiation, change, dose adjustment, or augmentation of psychotropic medication(s) is indicated
* The treating clinician thinks PGx testing can benefit and refers the patient to the study

Exclusion Criteria:

* Unwillingness to donate saliva samples for genetic analysis
* History of liver or bone marrow (hematopoietic cell) transplantation
* PGx testing results are already available
* No personal health identification number (PHIN) is available

Conditions6

Adverse Drug Reaction (ADR)AnxietyDepressionEffectivenessMental DisorderPharmacogenetics

Browse More Trials

Depression trialsAnxiety trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.